about
Patch testing with rubber series in Europe: a critical review and recommendation.Sweet's syndrome presenting as palmoplantar pustulosis.Allergic contact dermatitis to plant extracts in patients with cosmetic dermatitis.Corticosteroid cross-reactions: an alternative view.Effects of infection control measures on skin of health care workers.Allergy to oxidized limonene and linalool is frequent in the U.K.A multicentre review of the hairdressing allergens tested in the UK.A multicentre review of the footwear allergens tested in the UK.Materials and allergens within spectacle frames: a review.A review of the materials and allergens in protective gloves.Effective prescribing in steroid allergy: controversies and cross-reactions.Photopatch testing: recommendations for a European photopatch test baseline series.Methylchloroisothiazolinone and methylisothiazolinone contact allergy: an occupational perspective.The epidemic of methylisothiazolinone: a European prospective study.Methylisothiazolinone outbreak in the European Union.Minimum standards on prevention, diagnosis and treatment of occupational and work-related skin diseases in Europe - position paper of the COST Action StanDerm (TD 1206).Contact allergy resulting from the use of acrylate nails is increasing in both users and those who are occupationally exposed.European Surveillance System on Contact Allergies (ESSCA): results with the European baseline series, 2013/14.The three moments of skin cream application: an evidence-based proposal for use of skin creams in the prevention of irritant contact dermatitis in the workplaceContact allergy to preservatives: ESSCA* results with the baseline series, 2009-2012.Contact allergy to ingredients of topical medications: results of the European Surveillance System on Contact Allergies (ESSCA), 2009-2012.Current patch test results with the European baseline series and extensions to it from the 'European Surveillance System on Contact Allergy' network, 2007-2008.Occupational skin diseases: actual state analysis of patient management pathways in 28 European countries.Patch test clinic experience of potential cross-reactivity of isothiazolinones.Methylisothiazolinone: the epidemic is declining - but not gone.Allergic contact dermatitis in children: trends in allergens, 10 years on. A retrospective study of 500 children tested between 2005 and 2014 in one UK centre.ESSCA results with nickel, cobalt and chromium, 2009-2012.UK rates of occupational skin disease attributed to rubber accelerators, 1996-2012.Allergic contact dermatitis to henna tattoo.Concomitant contact allergy to methylchloroisothiazolinone/methylisothiazolinone and formaldehyde-releasing preservatives.False-negative patch test with levobunolol.Occupational contact dermatitis due to the epoxy hardener m-xylylenediamine.Chronic urticaria associated with intra-articular methylprednisolone.Systemic allergic contact dermatitis to 8-methoxypsoralen (8-MOP).Normolipaemic plane xanthomas: an association with increased vascular permeability and serum lipoprotein(a) concentration.The European baseline series in 10 European Countries, 2005/2006--results of the European Surveillance System on Contact Allergies (ESSCA).Type-IV hypersensitivity to betamethasone valerate and clobetasol propionate: results of a multicentre study.A prospective study into the value of patch and intradermal tests in identifying topical corticosteroid allergy.Contact leukoderma secondary to occupational toluenediamine sulfate exposure.Comparative testing with budesonide in petrolatum and ethanol in a standard series.
P50
Q30239887-02806490-BAC0-462E-A17E-EACDED9FC842Q33820706-709352E3-82BF-49AB-9FDC-EA5FAFBC7ECEQ33826379-26D79D52-F7A6-4247-9B5D-4DEF3CD62C78Q33854858-BCB4BC03-5977-4868-9766-43BBBB953DF0Q34203240-04761E3B-AF70-4D0B-9878-72A2A409848AQ34413687-E6EC23F1-55E5-47BF-B2EB-73F49450FA88Q36243370-7B87972D-0955-46DA-8F81-ED4EC7A92A07Q36243375-42F3170D-25BC-4C21-8547-0BBBFF3AF79BQ36570594-537318DE-D3E2-49D6-964A-79C556D39333Q37603384-D51135AF-A4E7-418C-90F3-31A71F147A7BQ37865718-1BE3017C-A100-498C-B694-C198BA197CE6Q38091143-0C798E9C-9100-4AA3-AF66-24B892FE331BQ38391497-24DA2FF1-F5B8-4D8A-895E-BA07B8438B95Q38403565-A3EDF019-3A47-4ACE-8014-C085FE8D319FQ38574079-4657AF16-FEAE-45B2-B44B-B5F204B5E098Q38665754-0925653D-8082-4CD5-9B42-677C70E77301Q38695828-97A39C65-CE76-44FA-84DB-D4D8FD7A85E1Q38719846-7762EE4A-E07C-4B42-BADB-4B5A6A2907E4Q38933180-BEF96C39-8E23-407D-9478-563CF08E4635Q39146273-5C76A65C-EE6A-4E53-93BF-A9B1BED55515Q39554059-60B3ED5F-8E8E-412C-9CB7-55A6D0A84305Q39629456-ACE2AA72-A669-4C6D-A0DE-136476392BDEQ40143059-F38E6114-7705-466B-95C0-2123D483CE37Q40253711-5195AE6B-081D-4196-8BD0-918BA6DAC4F7Q40253716-B4DDBED3-B56C-4BD7-8B3E-081C563A58EEQ40326304-D127DF76-2E32-444C-8C05-BDA15B61BB6BQ40664153-2233CEEB-DFB3-4E67-BF72-F153DA90C959Q41358044-E76BB23A-6C2E-49F5-A8D1-DE7C60869CE6Q43099919-5D87B476-D759-481E-9B9D-4D58F25465CFQ43171402-AE6BDC0B-1A15-4AB8-AF0A-3957088429ADQ43548800-5ACA350E-EB68-44D6-985E-9788F285A21FQ43647250-0D8BFC31-E65F-46CB-8139-5F94798CBCEAQ43650497-D18789E7-EB44-4790-B1B5-8CDDE766B821Q43801585-4C828674-7CF0-4193-9F6C-2F580C74E94AQ43940606-2919B701-BAC4-48F2-8597-9B2F338A53FFQ43953430-DB37D61D-7989-4563-ABE1-869CFA3FF54CQ44099062-1A7A620A-FC85-454A-825A-0F381CF8151FQ44157099-03C22E9B-2813-469A-B15A-10BA82D39025Q44210465-D8FC5264-A65B-4D10-BE14-56D2EC0202E1Q44210485-17BB9CFF-E6B5-4C68-B55C-A10FFDC95B22
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Stephen Mark Wilkinson
@ast
Stephen Mark Wilkinson
@en
Stephen Mark Wilkinson
@es
Stephen Mark Wilkinson
@nl
Stephen Mark Wilkinson
@sl
ستيفن مارك ويلكنسون
@ar
type
label
Stephen Mark Wilkinson
@ast
Stephen Mark Wilkinson
@en
Stephen Mark Wilkinson
@es
Stephen Mark Wilkinson
@nl
Stephen Mark Wilkinson
@sl
ستيفن مارك ويلكنسون
@ar
prefLabel
Stephen Mark Wilkinson
@ast
Stephen Mark Wilkinson
@en
Stephen Mark Wilkinson
@es
Stephen Mark Wilkinson
@nl
Stephen Mark Wilkinson
@sl
ستيفن مارك ويلكنسون
@ar
P106
P21
P31
P496
0000-0001-7253-3461